Pressure BioSciences Pressure Biosciences, Leica Enter Comarketing Deal for Mass Spec Sample Prep The platform combines Leica's laser microdissection tool and PBI's pressure cycling tech to enable better extraction and digestion of proteins from biopsies. Pressure BioSciences Q2 Revenues Up 6 Percent The company also disclosed that it dropped plans for a $12.5 million offering of stock and warrants following a recent reverse stock split. Pressure Biosciences Plans Reverse Stock Split The one-for-30 reverse split is intended to increase the price of the company's stock, enabling it to satisfy the Nasdaq's initial listing requirements. Pressure Bio Posts 8 Percent Revenue Growth in Q1 The revenue increase was driven by growth in sales of both instrument systems and consumables. Pressure Biosciences Q4 Revenues Up 15 Percent A 55 percent increase in the company's Q4 products and services revenues was softened by a 58 percent decrease in its grant revenues. Feb 2, 2017 Pressure BioSciences Lands CE Mark for Sample Prep Instrument Nov 16, 2016 Pressure Biosciences Q3 Revenues Fall 8 Percent Aug 16, 2016 Pressure Biosciences Q2 Revenues Up 24 Percent May 18, 2016 Pressure Biosciences Q1 Revenues Increase 16 Percent May 6, 2016 Aebersold Lab Employs New Pressure Bio Technology to Improve Swath-MS Analysis Premium Apr 6, 2016 Pressure Bio FY 2015 Revenues Up 31 Percent Feb 3, 2016 New Australian Cancer Research Facility to Profile 70K Tumor Proteomes Over Next Seven Years Premium Jan 12, 2016 Sciex and Pressure Biosciences Ink Comarketing Deal Dec 15, 2015 Pressure Biosciences Raises $730K in Fourth Closing of Private Placement Nov 12, 2015 Pressure Bio's Q3 Revenues Climb 56 Percent Oct 16, 2015 Pressure Bio, Florida International University to Collaborate on Rape Test Kit Technology Sep 28, 2015 Pressure Bio Closes $1.1M Tranche in Private Placement Aug 17, 2015 Pressure Bio Q2 Revenues Jump 34 Percent; Expenses Drive up Loss Jul 23, 2015 Pressure Bio Closes $2.2M Tranche in Private Placement May 18, 2015 Pressure Bio Q1 Revenues Rise 9 Percent but Firm Warns of Cash Shortage Apr 14, 2015 Pressure Bio, SUNO Collaborate to Expand PCT Applications Apr 1, 2015 Pressure Bio 2014 Revenues Shrink 7 Percent Feb 19, 2015 NHGRI Awards Pressure Bio $1M for NGS Technology Development Dec 30, 2014 Pressure BioSciences Receives $903K from Warrant Reset Agreements Nov 17, 2014 Pressure Biosciences Posts Q3 Revenue Decline, but Products and Services Sales Rise Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.